Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024

Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) has announced its quarterly dividend for the fourth quarter of 2024. The company's Board of Directors has declared a cash dividend of $1.24 per share on its common stock. This dividend will be payable on December 10, 2024 to shareholders of record at the close of business on November 26, 2024. The ex-dividend date is also set for November 26, 2024.

Positive

• Consistent dividend payment, indicating financial stability
• Maintaining shareholder returns through dividend distribution

Negative

• None.

Insights

Financial Analyst

J&J's consistent quarterly dividend of $1.24 per share underscores its commitment to shareholder returns and financial stability. This dividend maintains the company's status as a Dividend King, having increased dividends for over 50 consecutive years. The $1.24 quarterly payout translates to an annual dividend of $4.96 per share, yielding approximately 3% at current stock prices.

While dividend consistency is positive, investors should note that the lack of an increase might raise questions about growth prospects or cash allocation strategies. It's important to analyze this in context with J&J's recent separation of its consumer health business, Kenvue, which could impact future dividend policies. The maintained dividend suggests confidence in cash flow from remaining pharmaceutical and medical device segments, but also warrants attention to upcoming earnings and guidance for a complete picture of J&J's financial health and growth trajectory.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2024 of $1.24 per share on the company’s common stock. The dividend is payable on December 10, 2024 to shareholders of record at the close of business on November 26, 2024. The ex-dividend date is November 26, 2024.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241015885690/en/

Media contact:

media-relations@its.jnj.com



Investor contact:

investor-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

What is Johnson & Johnson's (JNJ) dividend amount for Q4 2024?

Johnson & Johnson's dividend for the fourth quarter of 2024 is $1.24 per share on the company's common stock.

When is the payment date for JNJ's Q4 2024 dividend?

The payment date for Johnson & Johnson's Q4 2024 dividend is December 10, 2024.

What is the record date for JNJ's Q4 2024 dividend?

The record date for Johnson & Johnson's Q4 2024 dividend is November 26, 2024, at the close of business.

When is the ex-dividend date for JNJ's Q4 2024 dividend?

The ex-dividend date for Johnson & Johnson's Q4 2024 dividend is November 26, 2024.